Compare AbCellera Biologics Inc (ABCL) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Gigacloud Technology Inc — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Gigacloud Technology Inc trades at $51 (market cap $1.84B). The key difference: AbCellera Biologics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ABCL | GCT | |
|---|---|---|
Market Cap | $2.99B | $1.84B |
Sector | Health | Technology |
52-Week High | $9.76 | $53.25 |
52-Week Low | $2.78 | $25.44 |
Enterprise Value | $2.58B | $1.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
